Equipmake Holdings (LON: EQIP) shares recovered 60% to 1.4p/share on the back of an increase in trading volumes. The share price is back to near the level it was in January.
Better news for Incanthera (LON: INC) this week. The dermatology technology developer has an agreement with the entity that claimed patent infringement relating to the Skin + Cell range. The agreement confirms no patent infringement. This had been delaying the launch of products, which are in stock. The focus will be generating cash from this stock. The deal with Limeway Pharma Design has been terminated and the two firms will cross licence patents on a royalty free basis. The development of the treatment for skin solar keratosis and prevention of skin melanoma can be done independently. The share price recovered 26.5% to 10.75p.
Coinsilium (LON: COIN) has launched its subsidiary Forza! in Gibraltar. The share price increased 9.09% to 3p.
Cryptocurrency app developer Tap Global Group (LON: TAP) increased interim revenues by 39% to £1.8m and it moved into a positive EBIDA of £324,000, while practically breaking even after tax. There was £890,000 in the bank at the end of 2024 and another £1m has been raised since then. Third quarter revenues are expected to be £920,000. The share price improved 6.67% to 1.6p.
Kondor AI (LON: KNDR) has finalised the terms of its bid for Ora Technology (LON: ORA) and it is 0.9848 of a share for each Ora Technology share. The shares have returned from suspension with Kondor AI up 2.5% to 10.25p and Ora shares are 5.53% higher at 10.5p. The enlarged group will provide a marketplace to enable AI developers to market their products.
Prize draws operator Good Life Plus (LON: GDLF) generated revenues of more than £3.7m in the year to January 2025. Monthly recurring revenues are £420,000. Subscriber numbers exceed 40,000. March 2025 is set to be a record month. Increased costs mean that there will be an operating loss of £4.3m. The Instant Wins product was launched in February 2025. The share price rose 2.7% to 1.9p.
FALLERS
Shares in Wishbone Gold (LON: WSBN) have returned from suspension 28.6% down at 0.125p after the proposed reverse takeover of Evrensel Global Natural Resources was terminated. Anthony Moore has left the board, and David Lenigas has joined as a consultant. A placing has raised £700,000 at 0.1p/share. The company requires £500,000 to pay for costs and other liabilities. One of the operating subsidiaries is being restructured and £190,000 of the cash is required to pay the reduced liabilities. The focus will be on gold prospects in Australia, particularly those near to the Telfer project owned by Greatland Gold (LON: GGP).
Marula Mining (LON: MARU) has approved a five-year budget for the 80%-owned Kilifi manganese processing plant. This should generate pre-tax operating project cash flow of $63.5m and $43.4m post-tax. The period starts in April. Environmental authorisation has been obtained for the Blesberg lithium and tantalum mine in South Africa. A deposit of £510,000 and a social labour plan and black economic empowerment transaction are required to receive the ten-year mining right. An environmental assessment is ongoing at the Kinusi copper mine in Tanzania. The share price declined 22.2% to 4.375p.
Janus Henderson has taken a 5.04% stake in Invinity Energy Systems (LON: IES). The share price dipped 10.8% to 8.25p.
IntelliAM AI (LON: INT) has appointed Jane Robinson as vice president for business development. It has also made other management appointments. The share price weakened 7.41% to 62.5p.
Arbuthnot Banking (LON: ARBB) increased loans by 2% to £2.4bn in 2024. Trading was tougher last year, and pre-tax profit fell from £47.1m to £35.1m. Total dividend were 69p/share, including a 20p/share special dividend. NAV is 1636p/share. The share price fell 3.54% to 885p.
Heart health products developer ProBiotix Health (LON: PBX) has signed a new partnership agreement with TopHealth in South Korea. TopHealth has the right to sell consumer products using ProBiotix Health, including the import of CholBiome X3. The share price slipped 2.78% to 8.75p.